1.30
6.47%
-0.09
Dopo l'orario di chiusura:
1.35
0.05
+3.85%
Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Operating Expenses
|
14.40%
4.3779
|
5.1146 | 3.115 | 3.4452 | 2.903 |
Income/Loss From Continuing Operations Before Tax |
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
Income/Loss From Continuing Operations After Tax |
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
Net Income/Loss
|
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,872%
15.47
|
0.3896 | 13.01 | 12.19 | 11.64 |
Diluted Average Shares |
3,872%
15.47
|
0.3896 | 13.01 | 12.19 | 11.64 |
Basic Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.24 | -0.28 | -0.25 |
Diluted Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.24 | -0.28 | -0.25 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):